RxDoctor Payments Data

William Knox, DO

Anesthesiology · Rolla, MONPI 1205989084

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,555 of the $3,598 with a category attached, or 71.0%. 18 manufacturers reported payments, led by Medtronic at 51.4% of the total. Reporting peaked in 2019 at $1,882 and has fallen 58.7% since, to $777 in 2025. Among anesthesiology clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,598in general payments, 2019–2025

Across 90 payments — averaging $39.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Foundation Fusion Solutions, LLC$548
  • Nevro Corp.$409
  • Biotronik NRO, Inc.$126
  • Stryker$110
  • Stimwave Technologies Incorporated$109
  • plus $446 from 12 others

What the payments were for

  • Travel & lodging$1,04429%
  • Food & beverage$2,55571%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,598 in reported general payments places this provider in the 95th percentile of 891 anesthesiology providers in Missouri.

See all anesthesiology providers in Missouri

Medicare billing

Part B allowed, 2024
$25,646
Medicare patients
85
Services billed
256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hysingla ErHydrocodone Bitartrate23$11,127
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen385$9,610
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen295$9,388
Pregabalin85$4,151
Xtampza ErOxycodone Myristate11$3,784
Morphine Sulfate ErMorphine Sulfate100$2,264
Tramadol Hcl ErTramadol Hcl39$1,962
Fentanyl11$1,682
Oxycodone Hcl78$1,416
Tramadol Hcl86$859
Morphine Sulfate22$457
Cyclobenzaprine Hcl13$254
Lidocaine-PrilocaineLidocaine/Prilocaine18$249
Diazepam141$141

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$36$3,78411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 891 anesthesiology providers in Missouri.

Other anesthesiology in Rolla

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →